A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Taletrectinib | CAS 1505514-27-1 - Request Quote

Picture of Taletrectinib

Taletrectinib

SZ CAT No:SZ-T225001
CAS No
1505514-27-1
Mol.F.
C23H24FN5O
Mol.Wt.
405.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Taletrectinib is chemically 3-(4-((R)-2-aminopropoxy)phenyl)-N-((R)-1-(3-fluorophenyl)ethyl)imidazo[1,2-b]pyridazin-6-amine. Taletrectinib is supplied with detailed characterization data compliant with regulatory guideline. Taletrectinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Taletrectinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1505514-27-1

Purchase 1505514-27-1

Order 1505514-27-1

Enquire 1505514-27-1

price of 1505514-27-1

1505514-27-1 Supplier

1505514-27-1 Manufacturer

1505514-27-1 Exporter

buy high quality Taletrectinib

Purchase Taletrectinib

Taletrectinib suppliers

Taletrectinib manufacturers

Taletrectinib price

Order Taletrectinib

Enquire Taletrectinib

Taletrectinib cost

Taletrectinib Supplier

Taletrectinib Distributor

Taletrectinib for Method Validation

Taletrectinib Reference Standard

Taletrectinib for ANDA Filing

Taletrectinib for Forced Degradation Studies

Taletrectinib Identification Standards

Taletrectinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,